Key Takeaways
- Steady quarter in a tough environment: Revenue held flat QoQ despite a domestic 1G ethanol Greenfield slowdown, while export mix compression shaved ~1% from margins.
- GenX pivot is now order-backed: The first U.S. CCUS order landed this quarter from a framework agreement, and management set a bold FY27 order booking target of not less than ₹500 crores.
- New technology announcements are ready, not revenue: Bio-IBA technology is ready for commercialization, and the SAF demo plant earned regulatory recognition, but both await policy triggers to convert into orders.
- Margins have a one-quarter visibility gap: Management expects quarter-on-quarter improvement but declined to call a steady run rate, citing dependency on Q4 execution mix and Mangalore facility absorption.
- What to watch next quarter: Whether the GenX pipeline converts beyond the first order, the pace of Mangalore's march to breakeven, and any SAF or Bio-IBA blending policy movement.
GenX: The Pivot from Energy Transition to Traditional Energy
- The shift in strategy: After the ETCA slowdown, Praj redirected its GenX facility toward traditional energy and new segments, securing audits and framework agreements with key customers.
- First CCUS order won: One of four framework agreements converted into an order this quarter from a global oil major for CCUS skids, with potential for more work under the same agreement.
- U.S. pipeline is the near-term driver: The first U.S. order has been received, the U.S. pipeline is described as very strong, and order revival from the U.S. side is expected to start happening.
- FY27 order booking ambition: Management set a target of not less than ₹500 crores in GenX order booking for next year, aiming to capture as many opportunities as possible in the first two quarters.
- Breakeven math: GenX breakeven requires a ballpark turnover of ₹400–500 crores, though the exact number depends on the nature and margins of the orders won.
- Data center adjacency: Praj is currently focusing on international markets for cooling system infrastructure (piping and frames), which is precision fabrication work, and is exploring other areas beyond this; India is seen as a future opportunity.
Sachin Raole: "We believe that this is just the beginning. I will not be able to tell you exactly what is going to happen in next quarter, but we will have to wait for one more quarter to see how the other customers are going to start placing order on GenX."
1G Ethanol: Greenfield Slowdown, Brownfield Resilience
- Greenfield projects are stalling: New domestic 1G ethanol Greenfield projects face a supply-demand imbalance, and existing project execution cycles are extending due to funding and other challenges.
- Brownfield is the offset: Strong traction in Brownfield solutions as customers prioritize operational efficiency and co-product additions like distillers corn oil (DCO).
- Subdued trajectory ahead: Management expects the subdued trajectory for new Greenfield ethanol projects to persist, with focus shifting to Brownfield performance enhancement and efficiency improvement projects.
- Policy backdrop is not negative: The NITI Aayog report on bio-fuels does not give a negative picture about the Ethanol Blending Program; it talks about expanding the entire basket beyond EBP to include CBG, flexi fuel, and additional blending, which management views as more encouraging.
New Technology Pipeline: Ready, Waiting on Policy
- Bio-IBA technology is commercialization-ready: Bio-Isobutanol technology development has progressed and the technology is ready for commercialization and scale-up; it is a molecule more amenable for blending in diesel than ethanol.
- SAF demo plant earns regulatory visibility: The integrated ethanol-to-jet demo plant at Praj's R&D center was appreciated at WINGS INDIA 2026, with the Joint Director General of DGCA announcing the development.
- SAF basic engineering is underway: Praj is executing basic engineering orders for ethanol-to-SAF plants for customers in the USA, planning to complete this work by the end of this fiscal; detailed engineering for one U.S. customer will finish by end of March or mid-April, after which the customer will decide on investments.
- Policy is the gating factor: A draft SAF blending policy is expected in the near future; for Bio-IBA, the government is actively discussing bio-fuel blending in diesel but no official announcement has been made.
- Competitive pushback acknowledged: An analyst noted that Balrampur Chini chose different technology partners for bio-plastic and TruAlt Energy chose another company for SAF; management responded that for Balrampur Chini, Praj may not have completed its technology offering at the time but is now ready, and for TruAlt, Praj was not involved in that discussion but certainly could have done the project if given the opportunity.
Ashish Gaikwad: "If your question is, had that opportunity been given to Praj? Yes, certainly we would have been able to do this project."
CBG: Slow and Steady, with Policy Tailwinds
- Two more plants commissioned: Two CBG plants using Napier grass and rice straw as mixed feedstocks were commissioned; production has started and capacity ramp-up is underway.
- Pressmud technology is working well: Management noted the Pressmud part is performing really well, and the company is going slow and steady because it is a technology company making sure the technology works.
- BPCL JV is gated by project count: The BPCL JV for CBG will start only when at least five projects are finalized; discussions and negotiations are ongoing to shortlist projects where a developer will also be part of it.
- Reliance CBG program is a future opportunity: Reliance has announced a large CAPEX program in Andhra Pradesh but has not yet engaged any vendors; Praj is one of their technology suppliers and expects to have a part to play when the opportunity opens up.
- Union budget support: Management hopes the CBG sector gathers further momentum due to positive union budget announcements.
Margins: Compressed by Mix, Recovery Deferred by a Quarter
- Export mix compression was the culprit: Overall margins were impacted by ~1% in Q3 due to a reduction in export revenue; Q3 had more deliveries to the Africa market where a large order includes construction activity, not just supply, compressing margins.
- Cost offsets were partial: Cost of material was up 8% but other expenses were down, compensating each other; employee benefit expenses reduced due to headcount rationalization based on the last three quarters' performance.
- Mangalore facility is the margin lever: Fixed cost absorption at the new facility will help margins return toward normal; the facility is on course to achieve breakeven in FY27, with Q4 providing more clarity.
- Management declined to call a steady run rate: When asked if the current ~5.6% margin should be a steady run rate incrementally, management said they expect quarter-on-quarter improvement but will have to wait for at least a quarter to say that, citing dependency on Q4 execution mix and Mangalore absorption.
- Path back to FY24 margins (10-11%): Fixed cost absorption, auto booking at Mangalore, sales mix, segment composition, geography, and volume will all help in returning to a normal margin scenario.
Order Book & Execution: Diversification in Motion
- Q3 order split: Domestic orders were 68% of the book, international 32%.
- Large orders won this quarter: A Greenfield brewery in India valued over ₹100 crores, and an integrated ZLD plant for a metal major also valued over ₹100 crores.
- Precision fermentation entry: A key order was received from Embio Limited in Dahej, the first contract under the National BioE3 Policy.
- Execution timelines: The brewery and ZLD orders have already started execution with a typical period of 12-14 months; conversion is expected in FY27. For the CCUS skids order, ~50% to 60% is expected to convert into revenue in FY27.
- International pipeline: Some orders from Latin America are already coming in due to increased blending mandates, though management did not name a specific new market expected to convert in the next 12 months.
- Cash position improving: Cash has gone up sequentially from Q1 to Q2 to Q3; receivables and inventory improved due to execution focus in Q2 and Q3.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| GenX order booking | Not less than ₹500 crores, with maximum capture aimed in first two quarters | FY27 |
| Mangalore facility breakeven | On course to achieve breakeven; Q4 will provide more clarity | FY27 |
| CCUS order revenue conversion | ~50% to 60% of the CCUS skids order to convert into revenue | FY27 |
| Brewery and ZLD order execution | Execution already started; typical period 12-14 months | Conversion in FY27 |
| SAF detailed engineering completion | Detailed engineering for U.S. customer to finish by end of March or mid-April; customer investment decision expected after that | Q1 FY27 |
| Margin recovery | Quarter-on-quarter improvement expected, but may take one more quarter; return to normal margin scenario depends on Mangalore absorption and sales mix | Q4 FY26 for trajectory clarity; no date for full recovery |
| 2030 revenue ambition of ₹10,000 crores | Fundamentals unchanged; whether reached by 2030 or 2031 depends on mandates assumed at the time; dependencies on policies and triggers | 2030 or 2031 |
| No additional manufacturing facilities | Investment for future growth already done; only plant and machinery additions for new segments if required; no further investment in factory or land | Ongoing |
Key Metrics
| Metric | Q3 FY26 |
|---|---|
| Consolidated income from operations | ₹841 cr, flat QoQ (₹842 cr in Q2 FY26) |
| PBT before exceptional items | ₹21.6 cr, down from ₹29.6 cr in Q2 FY26 |
| Exceptional item (labour code impact) | ₹334.4 cr incremental gratuity and leave liabilities |
| Profit after tax | ₹(12.4) cr, down from ₹19.3 cr in Q2 FY26 |
| 9M FY26 income from operations | ₹2,323 cr, down from ₹2,370 cr in 9M FY25 |
| 9M FY26 PBT before exceptional items | ₹60.8 cr, down from ₹210 cr in 9M FY25 |
| 9M FY26 PAT | ₹12.24 cr, down from ₹180 cr in 9M FY25 |
| Export revenue share | 34% of total revenue |
| Revenue mix | 71% bioenergy, 19% engineering, 11% PHS |
| Order intake | ₹914 cr, 68% domestic, up 12.4% QoQ |
| Order intake mix | 45% bio-energy, 42% engineering, 13% PHS |
| Order backlog | ₹4,491 cr, 66% domestic as of Dec 2025 |
| Cash in hand | ₹590 cr as of 31st Dec 2025 |
| GenX facility client audits completed | 12 audits, 4 framework agreements |
| GenX order booking target for FY27 | Not less than ₹500 cr |